Wendye Robbins - 31 Mar 2025 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact
Issuer symbol
RAPT
Transactions as of
31 Mar 2025
Net transactions value
+$52,502
Form type
4
Filing time
02 Apr 2025, 21:08:06 UTC
Previous filing
23 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Director Stock Option (right to buy) Award $52,502 +49,432 $1.06 49,432 31 Mar 2025 Common Stock 49,432 $1.22 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2025 with the first installment vesting on March 31, 2025, provided that the reporting person is in service as a director on the first day of the fiscal quarter of the applicable scheduled vesting date.
F2 This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $52,500.